About Covance
Covance is a company based in Princeton (United States) founded in 1996 was acquired by Pyxant in May 2021. Covance has completed 5 acquisitions, including GlobalCare Clinical Trials, PMI Preclinical and Rcri. Covance offers products and services including Central Lab Services, Nonclinical Studies, and Bioanalytical Services. Covance operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Princeton, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$304.41 K (USD), Grant
Mar 01, 2021
-
Investors
LabCorp
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
GlobalCare Clinical Trials
& 4 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Covance
Covance offers a comprehensive portfolio of products and services, including Central Lab Services, Nonclinical Studies, and Bioanalytical Services.
Provides testing for clinical trials and drug development processes.
Conducts toxicology and pharmacology for biopharma research.
Offers biomarker and genomics analysis for therapeutic development.
People of Covance
Unlock access to complete
Unlock access to complete
Software Development Team
172 people
Leadership Team
143 people
Sales and Marketing
52 people
Product Management Team
38 people
Human Resources and Administration
36 people
Operations Team
33 people
Data Analysis and Operations Team
32 people
Senior Team
29 people
Unlock access to complete
Funding Insights of Covance
Investors in Covance
Covance has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include LabCorp, European Union and Pyxant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked | |
|
GLP bioanalytical services for drug development are provided by Pyxant.
|
Locked | Locked | Locked |
Investor details for Covance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Covance
Covance has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include GlobalCare Clinical Trials, PMI Preclinical and Rcri.
Investment portfolio details for Covance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical site management, patient recruitment, and retention services are provided.
|
Locked | Locked | 2010 | Locked | |
|
A provider of strategic consulting and integrated clinical trial services to the medical device industry
|
Locked | Locked | 2009 | Locked | |
|
Scientific process outsourcing is delivered for life sciences firms.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Covance
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Covance
Detailed financials for Covance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Covance Comparisons
Peer comparison for Covance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Covance
Covance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Early drug development services are provided for pharma firms.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Covance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Covance
Complete news archive for Covance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Covance
Covance was founded in 1996 and raised its 1st funding round 17 years after it was founded.
Covance is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Covance was founded in 1996 in Princeton, United States, as a global contract research organization in the pharmaceutical sector. Services encompass drug discovery, lead optimization, analytical and safety assessments, clinical development, testing, manufacturing support, informatics, and health economics. Operations cover small molecules and biologics across therapeutic areas including cardiovascular diseases, oncology, and infectious diseases. The company was acquired by LabCorp in 2015.
Covance's top competitors include LabCorp, Charles River Laboratories and Cytel.
Covance offers Central Lab Services, Nonclinical Studies, and Bioanalytical Services.
Covance has made 5 acquisitions, including GlobalCare Clinical Trials, PMI Preclinical, and Rcri.
Covance has 3 investors. Key investors include LabCorp, European Union, and Pyxant.